Literature DB >> 15344359

Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine.

Victoria A Hampshire1, Frederick M Doddy, Lynn O Post, Teresa L Koogler, Tina M Burgess, Priscilla O Batten, Roderick Hudson, Dorothy R McAdams, Margarita A Brown.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15344359     DOI： 10.2460/javma.2004.225.533

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN： 0003-1488            Impact factor:   1.936


× No keyword cloud information.
  3 in total

1.  Long-term safety evaluation of Daxocox® tablets (enflicoxib) in dogs after weekly oral administrations for seven months.

Authors:  Josep Homedes; Marta Salichs; Antonio Guzman
Journal:  BMC Vet Res       Date:  2021-06-03       Impact factor: 2.741

Review 2.  Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.

Authors:  Francesca De Santis; Andrea Boari; Francesco Dondi; Paolo Emidio Crisi
Journal:  Animals (Basel)       Date:  2022-01-21       Impact factor: 2.752

3.  Efficacy and safety of deracoxib for the control of postoperative pain and inflammation associated with dental surgery in dogs.

Authors:  Stephen E Bienhoff; Eric S Smith; Linda M Roycroft; Elizabeth S Roberts; Larry D Baker
Journal:  ISRN Vet Sci       Date:  2012-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.